Actinium Pharmaceuticals reported $-5.49M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
AbbVie USD 3.69B 1.68B Mar/2026
Actinium Pharmaceuticals USD -5.49M 1.81M Sep/2025
Amgen USD 3.86B 1.28B Mar/2026
Bioline Rx USD -2.25M 1.7M Mar/2026
Capricor Therapeutics USD -27.23M 2.66M Jun/2025
Pfizer USD 6.01B 18M Jun/2026